An investigation for investors in NYSE:EBS shares concerning potential breaches of fiduciary duties by certain directors and officers of Emergent Biosolutions Inc was announced. Investors who are current long term investors in Emergent Biosolutions Inc (NYSE:EBS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The […]
Investor News: Deadline in Lawsuit against Keryx Biopharmaceuticals (NASDAQ:KERX) upcoming
A deadline is coming up on October 3, 2016 in the lawsuit filed for certain investors in NASDAQ:KERX shares over alleged securities laws violations by Keryx Biopharmaceuticals. Investors who purchased shares of Keryx Biopharmaceuticals (NASDAQ:KERX) have certain options and there are strict and short deadlines running. Deadline: October 3, 2016.. NASDAQ:KERX stockholders should contact the […]
Investor News: Investigation over possible Misconduct at Straight Path Communications Inc (NYSEMKT:STRP)
An investigation for investors in NYSEMKT:STRP shares was announced over potential breaches of fiduciary duties by certain officers and directors at Straight Path Communications. Investors who purchased shares of Straight Path Communications Inc (NYSEMKT:STRP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation by a […]
Investor News: Lawsuit against Orbital ATK Inc (NYSE:OA) filed
An investor, who purchased shares of Orbital ATK Inc (NYSE:OA), filed a lawsuitover alleged violations of Federal Securities Laws by Orbital ATK Inc. Investors who purchased shares of Orbital ATK Inc (NYSE:OA) bhave certain options and for certain investors are short and strict deadlines running. Deadline: October 11, 2016. NYSE:OA investors should contact the Shareholders […]
Investor News: Lawsuit against Keryx Biopharmaceuticals (NASDAQ:KERX) alleges Misleading Statements
An investor in NASDAQ:KERX shares filed a lawsuit over alleged violations of Federal Securities Laws by Keryx Biopharmaceuticals in connection with certain allegedly false and misleading statements. Investors who purchased shares of Keryx Biopharmaceuticals (NASDAQ:KERX) have certain options and for certain investors are short and strict deadlines running. Deadline: October 3, 2016. NASDAQ:KERX investors should […]
Investor News: Lawsuit against Emergent Biosolutions Inc (NYSE:EBS) alleges Misleading Statements
An investor in NYSE:EBS shares filed a lawsuit over alleged violations of Securities Laws by Emergent Biosolutions Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Emergent Biosolutions Inc (NYSE:EBS) =have certain options and for certain investors are short and strict deadlines running. Deadline: September 19, 2016. NYSE:EBS investors […]